Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents. Antimicrobial activity against gram-positive cocci and anaerobic bacteria isolated in 2000

Japanese Journal of Chemotherapy

Volumn 51, Issue 4, 2003, Pages 179-208

  Yoshida, Isamu ^a   Kimura, Yoshiji ^a   Higashiyama, Isao ^a   Sugimori, Giichi ^a   Yamano, Yoshinori ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Vancomycin

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFCAPENE; CEFDITOREN; CEFMETAZOLE; CEFOSELIS; CEFOTIAM; CEFOZOPRAN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTERAM; CEFTRIAXONE; DALFOPRISTIN PLUS QUINUPRISTIN; FLOMOXEF; FROPENEM; HABEKACIN; IMIPENEM; LINEZOLID; MEROPENEM; OXACILLIN; PENICILLIN G; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

AGAR GEL DIFFUSION; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; GRAM POSITIVE COCCI; GROWTH INHIBITION; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVOTELLA; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0038056147     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Japanese source. Chemotherapy 43: 12-26, 1995
2. Japanese source. Chemotherapy 44: 595-609, 1996
3. Japanese source. Chemotherapy 44: 610-625, 1996
4. Japanese source. Chemotherapy 46: 324-342, 1998
5. Japanese source. Chemotherapy 46: 343-362, 1998
6. Japanese source. 48: 585-609, 2000
7. Japanese source. 48: 610-632, 2000
8. Manual of Clinical Microbiology Seventh Edition: American Society for Microbiology, Washington, D. C., 1999
9. Japanese source. Chemotherapy 29: 76-79, 1981
10. Japanese source. Chemotherapy 27: 559-560, 1979
11. National Committee for Clinical Laboratory Standards (NCCLS): Twelfth Informational Supplement M100-S12, Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: NCCLS, 2002
12. Tsiodras S, Gold H S, Sakoulas G, et al.: Linezolid resistance in a clinical isolate of Staphylococcus aureus. LANCET 358: 207-208, 2001
13. Gonzales R, Schreckenberger P C, Graham M B, et al.: Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. LANCET 357: 1179, 2001
14. Johnson A P, Tysall L, Stockdale M W, et al.: Emerging Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Two Austrian Patients in the Same Intensive Care Unit. Eur. J. Clin. Microbiol. Infect. Dis. 21: 751-754, 2002
15. Fluit A C, Wielders C L C, Verhoef J, et al.: Epidemiology and Susceptibility of 3,051 Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study. J. Clin. Micribiol. 39: 3727-3732, 2001
16. Sanches I S, Mato R, Lancastre H D, et al.: Patterns of Multidrug Resistance among Methicillin-Resistant Hospital Isolates of Coagulase-Positive and Coagulase-Negative Staphylococci Collected in the International Multicenter Study RESIST in 1997 and 1998. Microb. Drug Resist. 6: 199-211, 2000
17. Japanese source. Jpn. J. Antibiotics 55: 568-655, 2002
18. Diekema D J, Pfaller M A, Jones R N, et al.: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. Int. J. Antimicrob. Agents. 13: 257-271, 2000
19. Japanese source. Jpn. J. Antibiotics 55: 730-763, 2002
20. Farrell D J, Morrissey I, Bakker S, et al.: Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother. 50 (S-1): 39-47, 2002
21. Japanese source. Jpn. J. Antibiotics 55: 537-567, 2002
22. Japanese source. Jpn. J. Antibiotics 55: 827-843, 2002
23. Felmingham D, Reinert R R, Hirakata Y., et al.: Increasing prevalence of antimicrobial resistance amaong isolates of Streptococcus pneumoniae from the PROTECT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50 (S-1): 25-37, 2002
24. Adam D: Grobal antibioitc resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50: (T-1): 1-5, 2002
25. Doern G V, Heilmann K P, Huynh H K, et al.: Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999-2000, Including a Comparison of Resistance Rate since 1994-1995. Antimicrob. Agents Chemother. 45: 1721-1729, 2001
26. Low D E, Azovedo J D, Weiss K, et al.: Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46: 1295-1301, 2002
27. Perez-Trallero E, Fernandez-Mazarrasa C, Garcia-Rey C, et al.: Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother. 45: 3334-3340, 2001
28. Ubukata K, Muraki T, Igarashi A, et al.: Identification of Penicillin and other Beta-Lactam Resistance in Streptococcus pneumoniae by Polymerase Chain Reaction. J. Infect. Chemother. 3: 190-197, 1997
29. Yokota S, Sato K, Kuwahara O, et al.: Fluoroquinolone-Resistant Streptococcus pneumoniae Strains Occur Frequently in Elderly Patients in Japan. Antimicrob. Agents Chemother. 46: 3311-3315, 2002
30. Karlowsky J A, Kelly L J, Critchley I A, et al.: Determining Linezolid's Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Rerease. Antimicrob. Agents Chemother. 46: 1989-1992, 2002
31. Japanese source. 52: 175, 1997
32. Japanese source. 50: 209-214, 2002
33. Japanese source. 59: 673-680, 2001
34. Pelaez T, Alcala L, Alonso R, et al.: Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin. Antimicrob. Agents Chemother. 46: 1647-1650, 2002
35. Wexler H M, Molitoris D, St. John S, et al.: In Vitro Activities of Faropenem against 579 Strains of Anaerobic Bacteria. Antimicrob. Agents Chemother. 46: 3669-3675, 2002